Your fight against malignant
pleural mesothelioma may
start here
OPDIVO with YERVOY is an FDA-approved immunotherapy option to treat previously untreated malignant pleural mesothelioma that cannot be removed by surgery
Actor portrayals.
Malignant pleural mesothelioma that cannot be removed by surgery
OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment for adults with a type of cancer that affects the lining of the lungs and chest wall called malignant pleural mesothelioma which cannot be removed by surgery.
OPDIVO (10mg/mL) and YERVOY (5 mg/mL) are injections for intravenous (IV) use.
It is not known if OPDIVO is safe and effective in children for the treatment of any other cancers.
OPDIVO + YERVOY will not work for everyone. Individual results may vary.
Patient stories
Explore videos of real patients sharing their experiences with OPDIVO and OPDIVO-based combinations.